Marianne P. Allen

Array ( [id] => 9081047 [patent_doc_number] => 20130266576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'THERAPEUTIC FACTOR VIII ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/822952 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13682 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13822952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776128 [patent_doc_number] => 20120039802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (CMET) AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/227213 [patent_app_country] => US [patent_app_date] => 2011-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 45663 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039802.pdf [firstpage_image] =>[orig_patent_app_number] => 13227213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766048 [patent_doc_number] => 20120034164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'TRUNCATED CAR PEPTIDES AND METHODS AND COMPOSITIONS USING TRUNCATED CAR PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/224193 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 77758 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034164.pdf [firstpage_image] =>[orig_patent_app_number] => 13224193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587861 [patent_doc_number] => 20110282371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'METHODS AFFECTING MARKERS IN PATIENTS HAVING VASCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 13/184944 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9578 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20110282371.pdf [firstpage_image] =>[orig_patent_app_number] => 13184944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8566049 [patent_doc_number] => 20120328620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'EPIDERMALGROWTH FACTOR RECEPTOR MUTATIONS' [patent_app_type] => utility [patent_app_number] => 13/184474 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 31932 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13184474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9756265 [patent_doc_number] => 20140286966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC SYNDROME, OBSTRUCTIVE RESPIRATORY DISORDERS, CANCER AND RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 14/123493 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18683 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574288 [patent_doc_number] => 20110269944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'HGF PRECURSOR PROTEIN VARIANT AND ACTIVE PROTEIN THEREOF' [patent_app_type] => utility [patent_app_number] => 13/175110 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11149 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269944.pdf [firstpage_image] =>[orig_patent_app_number] => 13175110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7790517 [patent_doc_number] => 20120052073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'Antibodies Directed to Angiopoietin-2 And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/169400 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 48891 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052073.pdf [firstpage_image] =>[orig_patent_app_number] => 13169400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8430846 [patent_doc_number] => 20120252722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'METAL-BINDING THERAPEUTIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/165688 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 32999 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13165688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043329 [patent_doc_number] => 20120071407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'METHOD OF TREATING WOUNDS' [patent_app_type] => utility [patent_app_number] => 13/163302 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7097 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071407.pdf [firstpage_image] =>[orig_patent_app_number] => 13163302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662278 [patent_doc_number] => 20110311547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Arthritis Treatment' [patent_app_type] => utility [patent_app_number] => 13/162705 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5735 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311547.pdf [firstpage_image] =>[orig_patent_app_number] => 13162705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8172512 [patent_doc_number] => 20120107953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'STABILIZATION OF INTERLEUKIN 6 IN SERUM BASED SOLUTIONS' [patent_app_type] => utility [patent_app_number] => 13/161793 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7827 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107953.pdf [firstpage_image] =>[orig_patent_app_number] => 13161793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8884764 [patent_doc_number] => 20130157949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'Novel Peptides for Wound Healing' [patent_app_type] => utility [patent_app_number] => 13/704471 [patent_app_country] => US [patent_app_date] => 2011-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8568 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11888028 [patent_doc_number] => 09758579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity' [patent_app_type] => utility [patent_app_number] => 13/152603 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 77451 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13152603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580865 [patent_doc_number] => 20110294748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Insulin-like growth factor 1 receptor binding peptides' [patent_app_type] => utility [patent_app_number] => 13/115523 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5887 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294748.pdf [firstpage_image] =>[orig_patent_app_number] => 13115523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10869825 [patent_doc_number] => 08895017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'HER-2 peptides and vaccines' [patent_app_type] => utility [patent_app_number] => 13/701814 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 11934 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670058 [patent_doc_number] => 20110319327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Polypeptides Homologous to VEGF and BMP1' [patent_app_type] => utility [patent_app_number] => 13/095097 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 38482 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13095097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854131 [patent_doc_number] => 20130143806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'METHOD FOR EARLY PROGNOSIS OF KIDNEY DISEASE' [patent_app_type] => utility [patent_app_number] => 13/641858 [patent_app_country] => US [patent_app_date] => 2011-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19017 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8815126 [patent_doc_number] => 20130116171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'METHODS FOR TREATING METABOLIC DISORDERS USING FGF' [patent_app_type] => utility [patent_app_number] => 13/641451 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 15961 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817953 [patent_doc_number] => 20120064573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES' [patent_app_type] => utility [patent_app_number] => 13/088830 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 41644 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064573.pdf [firstpage_image] =>[orig_patent_app_number] => 13088830 [rel_patent_id] =>[rel_patent_doc_number] =>)